ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Supernus Sues Apotex for Infringement of Oxtellar XR® Patents
July 07, 2020Supernus Pharmaceuticals announced it has sued generic drug maker Apotex Inc. and Apotex Corp. for infringement of nine patents covering its antiepileptic drug Oxtellar XR®. -
Pharma industry witnesses 50 deals worth $3 billion in April 2020
May 08, 2020Three major deals contributed 72 per cent of deal value in April 2020. -
Cadila Healthcare in pact with Supernus Pharmaceuticals
March 10, 2017Under the terms of the pact, Supernus grants a license to market Zydus generic version of Trokendi XR (topiramate) extended-release capsules beginning on January 1, 2023
Pharma Sources Insight January 2025
